HALO
#797
Halozyme Therapeutics, Inc. - Common Stock
110.7 6 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.00%
Changement Mensuel
+32.01%
Evolution sur 6 mois
+60.24%
Changement Annuel
+65.81%
Clôture Précédente
109.6 6
Open
110.7 6
Low
110.7 6
High
110.7 6
Volume
122
Financials
- Market Capitalization 12.57 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
22.89
ratio cours/chiffre d'affaires
5.77
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 751 |  SMMT Summit Therapeutics Inc. - Common Stock | 17.13 USD | +17.33% | +21.40% | +23.15% | -13.75% | 13.67 B USD | ||
| 782 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.43 USD | -0.81% | +2.22% | +8.09% | +17.28% | 12.86 B USD | ||
| 801 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 542.61 USD | -0.79% | +0.60% | +6.21% | +28.09% | 12.54 B USD | ||
| 813 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 86.49 USD | +1.31% | -1.45% | -1.14% | +121.20% | 12.22 B USD |